Details of the Drug Reposition
General Information of This Drug (ID: DMULZ4W)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | Tosedostat; Tosedostat, CHR2797, CHR-2797 | |||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2 Phase 2 Indication(s)
|
|
||||||||||||||||||||||||||||||
|
1 Terminated Indication(s)
|
|
||||||||||||||||||||||||||||||
References

